Vimarsana
Biggest News Aggregation in the World

Markets Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Markets Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Markets Corp Today - Breaking & Trending Today

JBS USA FOOD COMPANY ANNOUNCES TENDER OFFERS FOR CERTAIN OUTSTANDING SERIES OF NOTES - Vimarsana News

JBS USA FOOD COMPANY ANNOUNCES TENDER OFFERS FOR CERTAIN OUTSTANDING SERIES OF NOTES

/PRNewswire/ -- JBS USA Food Company announced today the commencement of tender offers to purchase for cash its outstanding series of notes listed in the table...

JBS USA FOOD COMPANY ANNOUNCES TENDER OFFERS FOR CERTAIN OUTSTANDING SERIES OF NOTES - Vimarsana News

JBS USA FOOD COMPANY ANNOUNCES TENDER OFFERS FOR CERTAIN OUTSTANDING SERIES OF NOTES

JBS USA Food Company announced today the commencement of tender offers to purchase for cash its outstanding series of notes listed in the table below (collectively, the "Notes") for a combined aggregate purchase price, excluding accrued and unpaid...

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR) - Vimarsana News

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR)

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering - Vimarsana News

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

SAN FRANCISCO, June 05, 2024 -- Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary...

Merus Announces Pricing of Upsized Public Offering of Common Shares - Vimarsana News

Merus Announces Pricing of Upsized Public Offering of Common Shares

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 -- Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the...